Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | $134.34B | 32.8x | 1.69 | $277.01 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.1% Upside | Upgrade to Pro+ | |
Ebos | Sydney | Healthcare | Pharmaceuticals | $6.51B | 23.6x | 3.83 | $33.57 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.5% Upside | Upgrade to Pro+ | |
Sigma Pharma | Sydney | Healthcare | Pharmaceuticals | $3.73B | -1,200x | 11.3 | $2.39 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -15.3% Downside | Upgrade to Pro+ | |
Neuren Pharma | Sydney | Healthcare | Pharmaceuticals | $2.13B | 18.1x | 0.16 | $16.71 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clinuvel Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | $666.79M | 18.5x | 1.06 | $13.28 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Botanix Pharma | Sydney | Healthcare | Pharmaceuticals | $572.50M | -35.3x | 2.71 | $0.32 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mayne Pharma | Sydney | Healthcare | Pharmaceuticals | $393.57M | -2.2x | 0.01 | $4.89 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.8% Upside | Upgrade to Pro+ | |
AFT Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | $231.75M | 16.4x | 0.38 | $2.21 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biome Australia | Sydney | Healthcare | Pharmaceuticals | $146.81M | -85.9x | -1.82 | $0.65 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.9% Upside | Upgrade to Pro+ | |
Vita Life Sciences | Sydney | Healthcare | Pharmaceuticals | $116.57M | 12x | 0.47 | $2.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Recce | Sydney | Healthcare | Pharmaceuticals | $113.62M | -5x | 0.19 | $0.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurizon Therapeutics | Sydney | Healthcare | Pharmaceuticals | $94.89M | -9.5x | 1.5 | $0.20 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Syntara | Sydney | Healthcare | Pharmaceuticals | $57.67M | -2.6x | -0.48 | $0.04 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Radiopharm Theranostics | Sydney | Healthcare | Pharmaceuticals | $56.50M | -0.2x | 0.09 | $0.03 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vitura Health | Sydney | Healthcare | Pharmaceuticals | $54.71M | 14.1x | -0.21 | $0.09 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inoviq | Sydney | Healthcare | Pharmaceuticals | $48.51M | -6.1x | -0.28 | $0.44 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medical Developments | Sydney | Healthcare | Pharmaceuticals | $48.44M | -0.9x | 0 | $0.44 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Next Science | Sydney | Healthcare | Pharmaceuticals | $43.82M | -2.7x | -0.08 | $0.14 | -10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Starpharma Holdings | Sydney | Healthcare | Pharmaceuticals | $43.82M | -5.5x | -0.1 | $0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Little Green Pharma | Sydney | Healthcare | Pharmaceuticals | $39.23M | -3.7x | -0.17 | $0.13 | -3.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 30.8% Upside | Upgrade to Pro+ | |
Oncosil Medical Ltd | Sydney | Healthcare | Pharmaceuticals | $35.87M | -1.6x | -0.06 | $0.008 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nyrada | Sydney | Healthcare | Pharmaceuticals | $23.06M | -6.1x | -0.2 | $0.11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Althea | Sydney | Healthcare | Pharmaceuticals | $21.33M | -0.5x | 0.01 | $0.04 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Calmer Co International | Sydney | Healthcare | Pharmaceuticals | $17.61M | -2.7x | -0.07 | $0.008 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immuron Ltd | Sydney | Healthcare | Pharmaceuticals | $17.19M | -2.5x | 0.03 | $0.08 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Argent BioPharma | Sydney | Healthcare | Pharmaceuticals | $15.47M | -0.6x | -0.01 | $0.28 | 3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Acrux | Sydney | Healthcare | Pharmaceuticals | $12.79M | -2.3x | 0 | $0.04 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anatara Lifesciences Ltd | Sydney | Healthcare | Pharmaceuticals | $11.19M | -5.8x | -0.16 | $0.06 | -9.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Firebrick Pharma | Sydney | Healthcare | Pharmaceuticals | $10.93M | -10.1x | -0.13 | $0.06 | 9.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TrivarX | Sydney | Healthcare | Pharmaceuticals | $7.77M | -4.3x | -0.08 | $0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |